Public Comments and Industry Interests in Medicaid Coverage Decisions.
Sign Up to like & getrecommendations! Published in 2019 at "JAMA internal medicine"
DOI: 10.1001/jamainternmed.2019.5077
Abstract: Invited Commentary Public Comments and Industry Interests in Medicaid Coverage Decisions In this issue of JAMA Internal Medicine, Ahn et al1 raise the intriguing question of whether treatments covered by Medicaid should be democratically decided.… read more here.
Keywords: coverage decisions; medicine; industry; public comments ... See more keywords
Comparing the Approval and Coverage Decisions of New Oncology Drugs in the United States and Other Selected Countries.
Sign Up to like & getrecommendations! Published in 2017 at "Journal of managed care & specialty pharmacy"
DOI: 10.18553/jmcp.2017.23.2.247
Abstract: BACKGROUND Global pharmaceutical sales for anticancer drugs were $74.4 billion in 2014, ranking first for drugs by therapeutic class. Countries may differ substantially in the approval and coverage decisions for anticancer drugs. OBJECTIVE To compare… read more here.
Keywords: coverage decisions; drug indications; oncology; approval coverage ... See more keywords
An Assessment of Real-World Evidence and Other Sources Supporting Payer Coverage Decisions for Pharmacogenomic Testing in Psychiatry
Sign Up to like & getrecommendations! Published in 2025 at "Journal of Personalized Medicine"
DOI: 10.3390/jpm15060232
Abstract: Background: Sources and evidence cited to inform payer coverage decisions on pharmacogenomic (PGx) testing in psychiatry are presently underexplored. Methods: We conducted a qualitative and quantitative assessment of publicly available coverage policies from 14 US… read more here.
Keywords: testing psychiatry; coverage; coverage decisions; evidence ... See more keywords